Meis2 is essential for cranial and cardiac neural crest development by Ondrej Machon et al.
RESEARCH ARTICLE Open Access
Meis2 is essential for cranial and cardiac
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Abstract
Background: TALE-class homeodomain transcription factors Meis and Pbx play important roles in formation of the
embryonic brain, eye, heart, cartilage or hematopoiesis. Loss-of-function studies of Pbx1, 2 and 3 and Meis1
documented specific functions in embryogenesis, however, functional studies of Meis2 in mouse are still missing.
We have generated a conditional allele of Meis2 in mice and shown that systemic inactivation of the Meis2 gene
results in lethality by the embryonic day 14 that is accompanied with hemorrhaging.
Results: We show that neural crest cells express Meis2 and Meis2-defficient embryos display defects in tissues that
are derived from the neural crest, such as an abnormal heart outflow tract with the persistent truncus arteriosus
and abnormal cranial nerves. The importance of Meis2 for neural crest cells is further confirmed by means of
conditional inactivation of Meis2 using crest-specific AP2α-IRES-Cre mouse. Conditional mutants display perturbed
development of the craniofacial skeleton with severe anomalies in cranial bones and cartilages, heart and cranial
nerve abnormalities.
Conclusions: Meis2-null mice are embryonic lethal. Our results reveal a critical role of Meis2 during cranial and
cardiac neural crest cells development in mouse.
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Background
Neural crest cells (NCC) represent a multi-potent em-
bryonic cell population that generates a very diverse
range of cell types including cranial nerves, neurons and
glia of the peripheral nervous system, enteric neurons,
melanocytes, cranial bones and cartilages [1, 2]. The first
NCC appear at the neurula stage in the neural plate
border region. As the neural tube closes in mouse, NCC
delaminate from the regions of neural plate border and
ectomesenchyme after epithelial-to-mesenchymal transi-
tion (EMT) and migrate to various developing organs.
The very broad differentiation potential of NCC provides
a complex model of cell type specification and migration
and the gene regulatory network determining the spatio-
temporal control of NCC diversification has been exten-
sively studied. For instance, the NCC population is
specified by the set of transcription factors Sox9, Sox10,
FoxD3, Snai2 together with Msx1, Pax3/7 or Zic1 in the
neural plate border [3]. These effector genes are regu-
lated by coordinated action of signaling pathways such
as Wnt, Bmp and Fgf from the adjacent paraxial meso-
derm and non-neural ectoderm [2, 4]. The differenti-
ation potential of NCC is spatially determined by their
position along the rostrocaudal axis. In a simplified view,
cranial NCC coming from mesencephalic and rhomben-
cephalic regions generate head bones, cartilages, cranial
nerves and selected connective tissues [5, 6]. Vagal NCC
from the area of somites 1-7 are destined to the enteric
nervous system. Cardiac NCC (somites 1-4) are involved
in septation of the cardiac outflow tract [7] and trunk
NCC form sensory and sympathetic ganglia. The current
debate, however, favors the scenario proposing that ori-
ginally multi-potent NCC stem cells are exposed to dif-
ferent environmental cues along the rostrocaudal axis
that spatiotemporally restrict their differentiation poten-
tial [1, 8].
Meis proteins are transcription factors that are ortho-
logous to the Drosophila homothorax (Hth) protein.
They contain a TALE (three-amino-acid loop extension)
sub-class of the homeodomain that binds to DNA. In
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humans and mice, three homologues Meis1, Meis2 and
Meis3 have been identified [9] and it has been shown
that they directly bind to Pbx proteins [10–12]. The
Meis/Pbx protein complex binds to DNA through re-
spective Meis- and Pbx-consensus binding sites thereby
regulating transcription. The Meis/Pbx complex plays
important roles during development of several organs
including limbs [13, 14], heart [15, 16], lens [17], pan-
creas [18] and hindbrain [19–22]. Hox genes are among
the target genes of Meis-Pbx control via modulation of
histone acetylation indicating recruitment of Hox pro-
teins as cofactors of Meis-Pbx complex [23, 24].
Mice lacking Meis1 display liver hypoplasia,
hemorrhage, impaired erythropoiesis and eye defects,
and die by the embryonic day (E) 14.5 [25, 26]. Although
a substantial amount of data have been reported on the
role of Meis1 in organogenesis, hematopoiesis and
leukemia induction, the function of the other homologs,
Meis2 and Meis3, is much less clear. Chicken Meis2 has
a specific role in determining cell fate in the midbrain-
hindbrain boundary by controlling the expression of
Otx2 [22] and it also affects proliferation of retinal pro-
genitor cells [27]. Several recent reports in various
model systems indicated that Meis2 may play a role in
neural crest cells. Meis2 was identified as one of the key
transcription factors in the gene regulatory network
driving differentiation of human embryonic stem cells
towards cardiovascular cell types, and this was further
confirmed by knock-down experiments in zebrafish [16].
Morpholino-based screens in zebrafish revealed the im-
portance of Meis1 and Meis2 factors during craniofacial
development [28]. Moreover, gene expression analysis of
EMT in endocardial cushions identified Meis2 among
enriched genes [29]. In this context it is very interesting
that some human disorders displaying cleft palate and
heart developmental defects have been linked to muta-
tions in the Meis2 locus [30–33]. Nonetheless, a clear
picture of the Meis2 function based on a genetic mouse
model is still missing.
In the present study, we examined the role of Meis2
during embryogenesis by generating conditional knock-
out mice. We studied morphological defects after either
zygotic inactivation of the Meis2 allele or NCC-specific
conditional knock-out using AP2α-IRES-Cre. We con-
clude that hemorrhaging most probably causes embry-
onic lethality. Further, many embryonic defects in the
tissues derived from neural crest in systemic Meis2-nulls
were recapitulated upon conditional deletion of Meis2 in
NCC suggesting an indispensable role of Meis2 in NCC.
Results
Meis2-/- embryos are lethal and display hemorrhaging
A conditional mutant allele of the Meis2 gene (Meis2
cKO) was created by inserting LoxP sites in the introns
2 and 6 that flank exons 3 and 6 in the Meis2 gene
(Fig. 1a). To generate mutant mice lacking functional
Meis2 in the whole organism, Meis2 cKO were at first
crossed with the Hprt1-Cre mice (Jax Mice and Ser-
vices) that exert a zygotic expression of Cre recombinase
facilitating gene excision in all tissues. The first gener-
ation mice, which were heterozygous for the Meis2 gene
(Meis2+/-), were intercrossed to obtain Meis2-null
(Meis2-/-) animals. Animals were genotyped using
primers flanking loxP sites as depicted in Fig. 1a. The
loss of exons 3-6 in Meis2-/- embryos was tested by
PCR (Fig. 1a, left). The absence of Meis2 protein was
verified using Western blot analysis of protein extracts
from E12.5 embryos (Fig. 1b, right). Meis2-/- mice dis-
played embryonic lethality between E13.5-E14.5 and suf-
fered from hemorrhaging (Fig. 1c). The size of mutant
embryos was smaller at E14.5 as mutant embryos
stopped growing approximately at E13.5 when hemor-
rhaging became prominent. Although the severity of this
phenotype varied among Meis2-/- (n = 29 litters, 51 mu-
tants), all mutants displayed bleeding and a small liver
size (Additional file 1: Figure S1B).
A detailed inspection of internal organs in mutant em-
bryos revealed that the liver was the most impaired
organ with a destructed cellular organization in large re-
gions (Additional file 1: Figure S1C-D). These impaired
regions contained almost no erythrocytes labelled with
Ter119 but many apoptotic cells as shown by TUNEL
assay (Additional file 1: Figure S1E-F). Surprisingly,
Meis2 was not found to be expressed in the fetal liver
while Meis1 was readily detectable (Additional file 1:
Figure S1A). Based on this we suggest that the observed
cell death in the liver is a consequence of strong hemor-
rhaging in the whole embryo that leads to anemia and
apoptosis primarily in the liver and may be a cause of
the embryonic lethality. Having observed anemia in
Meis2-/- embryos we further pursued the possibility that
Meis2 may influence embryonic hematopoiesis similarly
to Meis1 that controls proliferation of hematopoietic
stem cells in the fetal liver and is also essential for mega-
karyocyte viability [25, 26, 34]. We therefore mapped the
expression of Meis2 and Meis1 in the area of the aorta-
gonad-mesonephros (AGM), the site of origin of embry-
onic hematopoietic stem cells. As shown in Additional
file 1: Figure S2B, neither Meis2 nor Meis1 were ob-
served in endothelial cells labelled with CD31 but both
proteins were abundant in the mesenchyme surrounding
the endothelial wall of the dorsal aorta. We further
found that circulating hematopoietic progenitors labeled
with anti-Runx1 antibody did not express Meis2
(Additional file 1: Figure S2C). Finally, we carried out
erythroblast cultures derived from the fetal liver and
found no differences in the growth and differentiation of
liver erythroid progenitors between Meis2-/- and
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controls (data not shown). As Meis2, in our hands, was
not detected in hematopoietic progenitors neither in the
AGM nor in the fetal liver, we hypothesize that the
anemia in the mutants originates from extensive bleed-
ing or defective circulation rather than defects in
hematopoiesis.
The lack of Meis2 results in fetal heart malformation
In the heart of Meis2-/- embryos at E12.5, we observed
incomplete septation of the outflow tract that normally
separates the aorta from the pulmonary artery. This de-
fect is known as persistent truncus arteriosus (PTA) and
was observed in all analyzed mutants (n = 8 litters, 14
mutants) (Fig. 1d). To correlate the observed defects
with the expression of Meis2, we carried out immuno-
histochemistry on sections of embryonic heart at E13
using anti-Meis2 antibody. As shown in Fig. 1e, a
remarkably strong presence of Meis2 was observed in
the aortic and pulmonary valves. Strikingly, these valves
were lost in the Meis2-/- heart (arrowheads). To
visualize the PTA in the Meis2-/- outflow tract, we used
antibody against α-smooth muscle actin (SMA). Stained
heart sections confirmed the PTA but SMA appeared
normally expressed in the mutant heart (Fig. 1f ).
Widespread expression of Meis2 was observed in the
developing embryo including the central nervous system,
in the upper and lower jaw and in the lumen of the intes-
tinal tract (Fig. 2a). Specifically in the heart, Meis2 protein
was detected in the myocardium (arrow) and pericardium
(arrowhead) (Fig. 2a’) in which Meis2-positive cells also
expressed sarcomeric actin (Fig. 2f-f”, arrows). Remarkably
strong expression of Meis2 was found in the valves (aortic,
pulmonary, tricuspid and mitral) as well as in the atrio-
ventricular cushion (Fig. 2b-f”).
Fig. 1 Generation of Meis2 -/- mice. a Scheme of the Meis2 gene with 11 exons (black rectangles) and position of loxP sites for Cre
recombination. The homeodomain (HD) is encoded by exons 7-9. b Meis2-null (-/-) embryos were obtained by crossing Meis2 cKO with Hprt1-
Cre mice. Left: Genotyping of Meis2-/- embryos using primers loxF, frtF and frtR illustrated in (a) (see also Methods). Right: Western blot analysis
of E12.5 whole-embryo protein extracts with an anti-Meis2 antibody. c Mutant Meis2 mouse embryos at E14.5 display severe hemorrhaging. d
The embryonic heart at E13 with persistent truncus arteriosus (PTA) in which the aortic and pulmonary arteries are not separated in Meis2-/-. A
dashed line depicts the crossing of the separated aorta and pulmonary artery in the wild-type heart while this is not visible in the mutant outflow
tract. e Immunohistochemical staining of Meis2 in the embryonic heart at E13 (transverse sections) illustrating its strong expression in the aortic
(av) and pulmonary valves (pv). Aortic and pulmonary valves are missing in Meis2 mutants (arrowhead). f α-Smooth muscle actin (SMA) staining
on transverse sections showing persistent truncus arteriosus with the fused aorta (ao*) and pulmonary artery (pa*) in Meis2-/-. Ao, ascending and
descending aorta; pa, pulmonary artery; PTA, persistent truncus arteriosus
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To document heart defects in Meis2-/- embryos in de-
tail, we performed immunofluorescence on transverse
and sagittal sections from embryos at E12.5 using anti-
bodies against Meis2, α-smooth muscle actin (SMA) and
heart-specific myosin Myl7. Figure 3a-c illustrates that
the aortic and pulmonary arteries were not separated
(ao*, pa*, pv* in Fig. 3b) and the aortic valve was absent
(arrowhead in Fig. 3a). These regions strongly expressed
Meis2 in the controls and the signal was lost in the mu-
tants (Fig. 3a). Both the aortico-pulmonary spiral septum
and the aortic and pulmonary valves are formed from
from cardiac neural crest cells [7] which can be visual-
ized by anti-Sox9 and anti-Twist1 antibody [35]. In
Meis2-/- embryonic hearts, we observed less Sox9-
positive cells in the outflow valves. The number of
Twist1-positive cells was not significantly changed though
its expression level was reduced and the organization of
these cells was altered compared to controls (Fig. 3d).
Clear morphological defects in the septation of the trun-
cus arteriosus and in the outflow valves (arrowheads)
strongly suggest that the defective outflow tract in Meis2
nulls arises from impaired cardiac neural crest cells.
Neural crest cells express high levels of Meis2
Based on the heart abnormalities of potential neural
crest origin, we decided to map the expression of Meis2
at the embryonic stages that are critical for generation
and migration of NCC. At E8.5 before the neural tube
Fig. 2 Mapping of Meis2 expression in the mouse embryo at E13. Meis2 protein is present in many developing tissues including the forebrain,
midbrain, hindbrain, spinal cord, myocardium, cardiac cushions, cardiac outflow tract, valves (aortic, pulmonary, tricuspid, mitral). (a) A sagittal
section of the whole embryo with a detail of the heart (A’) documenting Meis2 presence in the myocardium (arrow) and pericardium
(arrowhead). (b-e) Transverse sections of the heart at E13 from rostral to caudal with details of the framed areas (b’-e’) illustrating strong Meis2
expression in cardiac valves. (f) Immunofluorescent labeling of sarcomeric actin in the wild-type heart at E13. (f’-f”) Double labeling of sarcomeric
actin (red) and Meis2 (green), a higher magnification view on the framed area in (f) showing Meis2 in the myocardium (arrows) and in the atrio-
ventricular cushion. ao, aorta; av, aortic valve;, pv, pulmonary valve; mv, mitral valve; avc, atrioventricular cushion
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closure, abundant Meis2 expression was noticed in the
neural plate that weakened towards the plate border
from which the premigratory NCC delaminate (Fig. 4a).
At E9.5, the Meis2 protein was found in the neuroepi-
thelium of the hindbrain (Fig. 4b-b”) in which the signal
became diminished towards the roof plate. Meis2 was
also seen in migrating cells in the mesenchyme lateral to
the hindbrain and in the pharyngeal arches 1-2 (PA1 and
PA2) (Fig. 4b’) and in the outflow tract (OFT) (Fig. 4B”).
Many of these cells especially in the PA co-express
Tfap2, a marker of NCC [36, 37] (Fig. 4c-c” and Add-
itional file 1: Figure S3C-D”). At E10.5, Meis2 protein
was detected in the developing tissues that are derived
from NCC, such as the trigeminal and facial nerve gan-
glions, in the the otic vesicle and its surrounding mesen-
chyme, in the maxillary and mandibular component of
the PA1, in the cardiac outflow tract cushion and in the
PA2 (Fig. 4d-d”’ and Additional file 1: Figure S3A-B”).
The expression pattern revealed by our immunohisto-
chemistry thus corresponds to in situ hybridization of
Meis2 mRNA reported by Cecconi and co-workers [38].
Apart from the neuroectoderm, many of Meis2-positive
cells displayed a mesenchymal character as revealed by
co-staining with the anti-Twist1 antibody (Fig. 2E and
Additional file 1: Figure S3E).
Conditional deletion of Meis2 in neural crest cells leads to
a defective heart outflow tract
Because some developmental defects in Meis2 nulls may
arise from affected NCC, we aimed to verify this as-
sumption by means of conditional inactivation of Meis2.
We employed AP2α-IRES-Cre (AP2α-Cre) transgenic
mouse in which Cre recombinase was inserted into the
Tfap2 (AP2α) gene enabling loxP recombination specifically
Fig. 3 Immunohistochemistry of transverse and sagittal sections at E13.5 from the embryonic heart in Meis2-/- mice and controls. a Anti-Meis2
antibody staining (brown) show strong expression in the pulmonary and aortic valve. The aortic valve is absent in the mutants lacking Meis2
(arrowhead). b α-Smooth muscle actin (SMA) staining showing the persistent truncus arteriosus (PTA) with the fused aorta and pulmonary artery
(presumptive ao* and pa*). Sagittal sections document a shortened heart length and a malformed pulmonary valve. c Heart-specific myosin light
chain 7 (Myl7) staining shows normal cell specification in the myocardium in Meis2 nulls and, again, absent aortic and abnormal pulmonary valve
on transverse and sagittal sections, respectively. d Left: Decrease of Sox9-positive cells in the valves in the outflow tract in Meis2 nulls. Right: The
level of Twist1 expression in the condensed mesenchyme in the pulmonary valve and in the tricuspid valve appears normal in the mutants but it
clearly reveals severe morphological changes in OFT. av, aortic valve; pv, pulmonary valve; tv, tricuspid valve; ao, aorta; pa, pulmonary artery
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Fig. 4 (See legend on next page.)
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in NCC [39]. Conditional mutants AP2α-Cre/Meis2 cKO
survived the critical stage E14, at which systemic Meis2
nulls die, but they were lethal around the time of birth. This
cKO approach also allowed us to analyze older embryos.
To perform lineage tracing experiments and examine mi-
gratory routes of NCC, conditional mutants AP2α-Cre/
Meis2 cKO were crossed to ROSA26 reporter mice [40].
This allele allows detection of Cre-mediated recombination
using β-galactosidase enzymatic assay and tracing of all cells
derived from AP2α-Cre positive NCC. Figure 5a-a’ illus-
trates lineage tracing of NCC in normal and AP2α-Cre/
Meis2 cKO embryos. 75 % of mutants (n = 8 litters, 8 mu-
tants) displayed aberrant distribution of β-galactosidase-
positive cells along the neural tube (arrow in 5A’), and all
mutants had abnormalities in the PA2, which appeared
thinner and misshaped, (arrowheads in 5A-A’) and also all
mutants had smaller otic vesicles (asterisks). Sectioning of
AP2α-Cre/Meis2 cKO/ROSA26 E10.5 embryos revealed
poor colonization of the OFT by cardiac NCC (arrows in
5B-B’). Conditional deletion of Meis2 effectively erased the
Meis2 protein in the regions of the AP2α-Cre activity, how-
ever, many surrounding cells still express normal levels of
Meis2 (arrows in Fig. 5c-c’). Next we studied the OFT de-
fects at later stages using immunohistochemistry on cryo-
sections from AP2α-Cre/Meis2 cKO/ROSA26 embryos. At
E11, anti-Sox9 antibody labelled all β-galactosidase-positive
cells in the OFT and we observed a lower density and
disorganization of double-labelled cells in conditional mu-
tants (Fig. 5d-d’). 90 % of mutants had malformed OFT
valves at E12 (n = 5 litters, 9 mutants) (such as av in Fig. 5e-
e’). However, the septation of the truncus arteriosus ap-
peared normal in conditional mutants as the aorta and pul-
monary arteries were normally separated (Fig. 5 f-f ’), which
was never seen in systemic nulls all displaying the PTA. Of
note, we detected still high levels of Meis2 in non-
recombined cells, including the smooth muscle of artery
walls and in the vicinity of valves, which may provide ex-
planation for less severe defects in conditional mutants
compared to systemic ones. Finally, Fig. 5g-g’ shows an ex-
ample of valve malformation at E14 known as double outlet
right ventricle (DORV) labelled with anti-Sox9. In sum-
mary, tissue-specific deletion of Meis2 using AP2α-Cre re-
sulted in various valve defects in the heart outflow tract
documenting its critical role in cardiac NCC.
Meis2 affects cranial nerve development
As Meis2 expression is abundant in the head region, we
next explored other NCC derivatives such as cranial
nerves. Formation of their neuronal projections in
Meis2-/- embryos was followed using whole-mount im-
munostaining of neurofilaments with the 2H3 antibody.
As seen in Fig. 6a-b’, the trigeminal (cranial nerve V), fa-
cial (VII) and vestibulocochlear (acoustic) nerves (VIII)
were severely impaired in Meis2 nulls at E10.5 (asterisks
in Fig. 6b’). An analogous analysis was performed in
AP2α-Cre/Meis2 cKO. We again crossed conditional
mutants with ROSA26 reporters to map the activity of
Cre. β-galactosidase signal in AP2α-Cre/ROSA26 con-
trols was seen in trigeminal ganglions, the lens, the
periocular mesenchyme and the surface ectoderm. A
similar spatial pattern in this head region was found in
the mutants AP2α-Cre/Meis2 cKO/ROSA26 and the size
of the trigeminal ganglion V was smaller and misshapen
(Fig. 6c’). 2H3 neurofilament staining showed that the
cranial nerves VII and VIII were damaged in conditional
mutants (asterisks in Fig. 6d’) but the trigeminal nerve V
again less affected than in Meis2-/- (n = 3 litters, 3 mu-
tants). Thus, the phenotype in cranial nerves appeared
weaker in conditional mutants in comparison with sys-
temic ones. We further noticed that the cornea and eye-
lids were not developed properly (Fig. 6e-e’) (similarly in
Meis2-/- embryos at E13.5, not shown). The cornea was
much thinner (arrow) while eye lids (el) did not grow
and close over the eye bulbs. The cornea was reported
to originate from NCC [41–43] as also indicated by our
lineage tracing data showing AP2α-Cre activity in the
periocular mesenchyme (Fig. 6c). In summary, tissue-
specific deletion of Meis2 in NCC and the surface ecto-
derm resulted in malformed cranial nerves, the cornea
and eyelids.
Development of cranial cartilage is perturbed in Meis2-
null embryos
Next, we examined the development of the craniofacial
skeleton that is derived from NCC. Mapping of AP2α-
Cre/ROSA26 showed complete recombination in PA1
and otic vesicle at E10 and this was further verified at
E13 on sagittal view in which recombined cells resided
in jaws and the nasal cartilage (Fig. 7a). Immunostaining
(See figure on previous page.)
Fig. 4 Meis2 is expressed in migrating NCC. (a) Meis2 expression in the neural plate stage at E8.5 becomes weak towards the neural plate border
(arrows). Right: schematic embryo at E8.5 with a depicted section plane (dashed). (b-b”) Sections from rostral (b‘) to caudal (b‘’) of wild-type em-
bryos at E9.5 revealing Meis2 in pharyngeal arches (PA), hindbrain (H) and in the cardiac outflow tract (OFT). (c-c”) Immunofluorescent double-
labeling of Meis2 (green) and Tfap2 (red) in the region approximately depicted by a black rectangle in A’. (d-d”’) Transverse sections from rostral
to caudal at E10.5 with immunostained Meis2. Sections levels correspond to the illustrated cartoon. Meis2 was detected in the hindbrain (H),
forebrain (F), optic cup (OC), trigeminal nerve ganglion (V), otic vesicle (OV), facial nerve ganglion (VII), maxillary (Mx) and mandibular (Mb) process
of PA1, in PA2 and outflow tract (OFT). (e) Immunofluorescence of Meis2 (green) and Twist1 (red) shows their co-expression in two areas labelled
with rectangles in D”’. Upper panels (1) belong to the lateral zone (1) and lower panels (2) to the midline area (2)
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Fig. 6 The absence of Meis2 leads to perturbed development of cranial nerves. (a-a’) Neurofilament staining using 2H3 antibody revealed absent
or abnormally positioned cranial nerves trigeminal V, facial VII and vestibulocochlear VIII in Meis2-/-. (b-b’) A detail of the framed areas in (a)
showing severed nerves V, VII (asterisks). (c-c’) Lineage tracing of NCC in AP2α-Cre /Meis2 cKO/ROSA26 embryos at E10.5 and controls. Transverse
head sections in the eye area. (d-d’) Neurofilament 2H3 staining of cKO embryos at E10.5 with impaired nerves VII and VIII (asterisks). (e-e’)
Hematoxylin-eosin staining of the eye from cKO at E17 shows shrunken eyelids (el) and cornea (arrow). Cranial nerves III, V, VII, VIII, X; el, eye lid;
oc, optic cup; pm, periocular mesenchyme
(See figure on previous page.)
Fig. 5 Heart defects upon conditional inactivation of Meis2 in NCC. (a-a’) Lineage tracing of NCC in AP2α-Cre /Meis2 cKO/ROSA26 embryos at
E10.5 (a’) and controls (a). (b-b’) Sections of embryos shown in (a) at the level of PA2 and OFT, compare position and number of β-galactosidase-
positive cells in the control and the mutant cKO (arrows in B’). (c-c’) Immunohistochemical staining of Meis2 in cKO (c’) shows the areas of its de-
letion. (d-d’) Cryosetions of the OFT from AP2α-Cre /Meis2 cKO/ROSA26 stained for β-galactosidase and Sox9, note cells disorganization in cKO
(d’). (e-e’) Paraffin-embedded sections of E12 heart stained with anti-Sox9 defective aortic valve in cKO (e’). (f-f’) Meis2 and β-galactosidase
double-labeling of E13 OFT shows a number of Meis2-positive cells in cKO (f’) that are excluded from Cre recombined areas. The pulmonary valve
does not develop properly. (g-g’) anti-Sox9 immunohistochemical labeling of severed valves in cKO at E14 (g’). Ao, aorta; av, aortic valve; OFT,
outflow tract; PA2, pharyngeal arch 2; pa, pulmonary artery, DORV, double outlet right ventricle
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of the Meis2 protein confirmed efficient deletion in
AP2α-Cre /Meis2 cKO in the regions of Cre recombin-
ation (asterisk in Fig. 7b’, compare with the panel 7a).
We found abnormal palate (p) and tongue (t) in sagittal
sections of E14 conditional mutants (Fig. 7c-c’). The size
of tongue was greatly reduced and muscle fibers looked
disorganized, as shown in a detailed view on transverse
sections (Fig. 7d-d’). In 33 % of mutants (n = 6 litters, 4
mutants), severely malformed developing cartilage were
observed in the palate (asterisk in Fig. 7e’), 67 % of
Fig. 7 Conditional inactivation of Meis2 in NCC affects osteochondrogenesis in the head. (a-a’) Illustration of the zone of Cre activity visualized in
AP2α-Cre/ROSA26 embryos, left: transverse section of E10.5 embryo, right: sagittal view on E13.5. (b-b) Meis2 immnunostaining of AP2α-Cre/
Meis2cKO embryos at E10.5, transverse sections in the region of hindbrain and the first pharyngeal arch. Compare the area of Meis2 deletion with
a comparable cryosection from AP2α-Cre /Meis2 cKO/ROSA26 in the left panel (a). (c-c’) Sagittal sections from cKO at E14, hematoxylin-eosin
(H&E) staining. Note the abnormal palate (p*) and tongue (t*). (d-d’) A higher magnification of the tongue on transverse sections at E14 docu-
ments its much reduced size and tissue disorganization. (e-e’) An example of severely disrupted palate (p*) in some cKO embryos, transverse sec-
tion H&E staining. Alcian staining of cartilage at E16 with no otic capsule in cKO. (g-g’) Submandibular gland is almost absent and tongue muscle
severed, transverse sections. (h-h’) Alizarin Red/Alcian Blue staining of E17.5 heads. Side view with remarkably shorter mandible (arrow), absent
interparietal bone, abnormal hyoid bone and otic capsule cartilage. Ossification frontline of the parietal bone is severed in the mutants (arrow-
head). (i-i’) Ventral views showing an abnormal hyoid bone (asterisk). oc, otic capsule cartilage; ip, interparietal bone; hy, hyoid bone; mb, man-
dible, p, palate; pr, parietal bone; smg, submandibular gland; t, tongue
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mutants also displayed abnormal palates though less se-
vere. Further, the otic capsule cartilage was absent as
shown by Alcian staining at E16 (asterisk in Fig. 7 f ’).
Submandibular gland (smg) was missing in 33 % mu-
tants and 66 % had much smaller smg (Fig. 7g-g’) (n = 6
litters, 4 and 8 mutants, respectively). We carried out
whole-mount Alcian Blue/Alizarin red staining at E17.5
that confirmed our observations from tissue sections:
The mandibular bone was poorly developed and its
length was much shorter in the mutants (black arrow in
Fig. 7h’). The interparietal bone and the cartilage of the
otic capsule were absent and the boundary of ossifica-
tion of the parietal bone was abnormal (arrowhead in
Fig. 7h’). The hyoid bone was severely malformed (aster-
isk in Fig. 7i’). These defects clearly document that
Meis2 is essential for the head bones and cartilages that
originate from cranial NCC.
Meis2 does not affect proliferation and expression of
main determinants of NCC
Migrating NCC are exposed to a number of environ-
mental factors that can alter their properties including
fate restriction or proliferation. In order to class Meis2
into the gene regulatory network determining NCC de-
velopment we first examined the levels of expression of
well-known genes specifying NCC. Trigeminal ganglions
stained with anti-Pax3 were found reduced in size or
completely missing in Meis2-/- embryos at E10 (Fig. 8a-
A’). Conditional mutants showed normal levels of Pax3
and a normal size of ganglions V (not shown). Pax3 was
reported to control colonization of the OFT by cardiac
NCC [44] and the promoter of Pax3 is directly con-
trolled by Pbx1 [45]. As Pbx1-/- embryos display similar
heart defects as Meis2-/- embryos [15], we checked the
expression of Pax3 in the OFT and PA2 of our mutants.
Fig. 8 Expression of NCC markers in the absence of Meis2. (a-a’) Pax3 immnostaining of trigeminal ganglions in systemic Meis2-/- E10.5 embryos
showing greatly reduced or even absent ganglions V. (b-b’) Pax3 in the second pharyngeal arch (PA2). (c-c’) Tfap2 immunostaining in Meis2-/-
embryos at E10.5. (d-d’) Sox10 immunofluorescence of ganglions V at E10.5. (e-e’) Melanocytes stained with anti-Mitf were detected normally in
Meis2 nulls. (f-f’) Sox10 in dorsal root ganglia and the peripheral nervous system was not changed in mutants. DRG, dorsal root ganglia; H, hind-
brain; V, trigeminal ganglion; PA2, the second pharyngeal arch;, sc, spinal cord
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However, we found no change in Pax3-positive cells in
PA2, moreover, Pax3 was not detected in the OFT even
in wild-type controls (Fig. 8b-b’). Next we assayed the
level of expression of Tfap2, Sox10 and Mitf, a marker of
melanocyte precursors. As shown in Fig. 8c-f ’, their ex-
pression was not found to be changed in the absence of
Meis2.
We also analyzed the number and spatial distribution
of migrating NCC using anti-Sox9 antibody at E10.5.
Sox9-positive NCC are abundant in the embryonic head
mesenchyme and pharyngeal arches, however, their
quantification did not reveal significant changes between
controls and mutants (Additional file 1: Figure S4A).
Further, we examined cell proliferation using antibodies
against PCNA and PH3 on head sections. Again, quanti-
fication of all proliferating cells (all PCNA+ or PH3+) or
proliferating NCC (Sox9+/PCNA+) did not differ be-
tween controls and mutants (Additional file 1: Figure
S4B-D). Finally, apoptosis, as measured by anti-Cas3 im-
munohistochemistry at E10.5, was not significantly al-
tered in the mutants (Additional file 1: Figure S4E). In
summary, Meis2 absence did not result in dramatic
changes in cell proliferation and viability at E10.5.
Systemic Meis2 mutants show aberrant position of FoxD3
and Sox9
As the defects in NCC derivatives in the absence of
Meis2 were not caused most probably by insufficient cell
proliferation or changed expression of main NCC
specifiers we performed whole-mount in situ
hybridization to map the position of migrating NCC. At
first, E9.5 embryos from Meis2-/- embryos and control
littermates were stained with riboprobes for FoxD3 and
Sox9 mRNA [46, 47]. As shown in Fig. 9A-B, both
FoxD3 and Sox9 were expressed in Meis2-/- embryos at
the levels that were comparable to control littermates,
indicating again that the overall differentiation program
of NCC was not affected. Interestingly, we observed an
aberrant position of FoxD3-positive cranial NCC in
Meis2 nulls (arrows in Fig. 9a-a’). Expression of FoxD3
mRNA in the trigeminal ganglion confirmed its abnor-
mality as also seen in Fig. 6b’. Sox9 mRNA revealed that
otic vesicles were consistently smaller in mutants (arrow
in Fig. 9b’). Next, we carried out the same analysis in
E9.5 embryos from conditional mutants AP2α-Cre/
Meis2 cKO. However, the levels and distribution FoxD3
and Sox9 transcripts were not altered in conditional mu-
tants (n = 5 litters, 8 mutants) (Fig. 9c-d’). Thus, the
changes in the expression pattern of NCC specifying
genes Sox9 and FoxD3 were found to be more profound
in systemic Meis2 mutants compared to conditional
ones which may explain their stronger phenotypic
defects.
Discussion
In this study, we showed that the transcription factor
Meis2 is abundant in NCC and it is essential for their
function. The embryonic lethal phenotypes of mutant
Fig. 9 Expression of neural crest cell specifier genes FoxD3 and Sox9 in the absence of Meis2. (a-a’) In situ hybridization of FoxD3 on E9.5
Meis2-/- embryos and controls with an abnormal position of migrating NCC in the midline of the midbrain, hindbrain and spinal cord (arrows in
side and dorsal views in a’). (b-b’) Sox9 mRNA staining at E9.5 with ectopic cells in the midline (arrows in side and dorsal views in (a’) and smaller
otic vesicles (arrowheads) in systemic mutants. (c-c’) In situ hybridization of neural crest cell specifier mRNA FoxD3 and Sox9 (d-d’) in conditional
AP2α-Cre/Meis2cKO at E9.5. Side and corresponding dorsal view magnifications illustrate no change in their expression in conditional mutants
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mouse embryos of Meis2 and its paralogue Meis1 are
similar in the timing of death and in strong hemorrha-
ging. Meis1 is expressed hematopoietic stem cells in the
fetal liver, the primary organ of hematopoiesis at E13.
Various assays showed defects in erythropoiesis provid-
ing explanation for anemia in Meis1 mutants [25, 26]. In
contrast, we did not detect Meis2 in the fetal liver and
in hematopoietic progenitors in the dorsal aorta. We
therefore speculate that hemorrhaging in Meis2-/- em-
bryos caused destructive changes primarily in the fetal
liver that is highly sensitive to low oxygen. Impaired
function of the liver may lead to failure in erythropoiesis
and thus bleeding rather than defects in hematopoiesis
in Meis2 mutants may cause lethality. Despite 83 % se-
quence identity of Meis1 and Meis2 and the almost
identical homeodomain, they acquired different func-
tions during evolution probably due to distinct expres-
sion patterns.
Stankunas and colleagues [15, 45] showed that various
combinations of mutant alleles of Pbx1/2/3 or Meis1 ex-
hibit cardiac anomalies in the outflow tract or in the
septation of ventricles implying that cardiac NCC re-
quire transcriptional control by combinatory Meis/Pbx
complexes. Along this line, zebrafish Meis2 genes influ-
ence development of heart and cranial skeleton [16, 28].
The data presented here extend our knowledge about
the role of Meis/Pbx complexes controling the fate of
NCC. Apart from the previously proposed function in
cardiac neural crest, we suggest that a similar transcrip-
tional control network takes place in cranial NCC in-
cluding chondrogenic and neuronal lineages. Our data
represent the first loss-of-function study of Meis2 in
mouse and may in fact serve as a disease model for cer-
tain human developmental disorders. Intriguingly, sev-
eral reports describe patients with Meis2 mutations who
display disorders such as the cleft palate, septal defects
in the heart or intellectual disabilities [30–33].
Pax3 is expressed in the neural plate border and plays
an important role in cardiac NCC as documented by
conditional knock-out studies in mouse [44]. A specific
Pbx1/Meis1 complex has been reported to directly regu-
late Pax3 in premigratory NCC in rhombomeres, in
which cardiac NCC originate, linking Pbx1-Pax3 regula-
tory hierarchy with the OFT defects in Pbx1-/- embryos
[45]. We did not see reduced Pax3 expression in
Meis2-/- at E10.5 although Pax3-positive trigeminal gan-
glions were shrunken in systemic mutants. Nor could we
detect Pax3 in the wild-type OFT at E10.5. It is possible
that Meis2 and Pax3 are co-expressed in earlier NCC in
which these factors may cooperate during NCC
differentiation.
Our experiments utilizing conditional mutants AP2α-
Cre/Meis2 cKO confirm defects in tissues derived from
cardiac and cranial NCC such as the OFT or craniofacial
cartilage. However, the phenotypes in cKO appeared in
some cases weaker than in systemic mutants. PTA, for
instance, was never found in conditional mutants while
all systemic mutants displayed defective septation of the
OFT. It is important to note that we still found a sub-
stantial amount of Meis2 protein after conditional dele-
tion in the areas that are in close vicinity of AP2α-Cre
targeted regions (mapped in the ROSA26 reporter) in
which we observed effective inactivation. Standby
Meis2-positive cells may be involved in forming the
truncus septum. Although AP2α-Cre mouse is the earli-
est driver for NCC [44], we cannot exclude the possibil-
ity that a minor NCC population forms before AP2α-
Cre mediated recombination and thus it is not targeted.
Another possibility is that neighboring non-NCC cells
expressing Meis2 participate in the truncus septation. In
this context it is interesting to note that systemic Pax3
KO display the PTA while Wnt1-Cre or AP2α-Cre cKOs
of Pax3 show valve defects but normal separation of
aorta and pulmonary arteries [44]. Moreover, the PTA
defects were also seen in systemic Pbx1-3 mutants; the
data from Pbx cKOs are not available [15, 45]. The fact
that the truncus septation may partially originate from
non-NCC population is supported by the report of Bai
and colleagues [48] who observed PTA in Mef2c-Cre/
Bmp4/7, a Cre driver not normally used for NCC
targeting.
Altered proliferation, apoptosis or significant changes
in expression of transcription factors determining NCC
(Sox9, Sox10, Tfap2, Pax3, Mitf ) were not detected be-
tween critical stages E10.5-E11.5 in our hands. Meis2
may influence late phases of NCC differentiation (in-
cluding cell proliferation and viability) that is required
for proper formation of the OFT or for differentiation of
osteochondral progenitors.
We hypothesize that Meis2 absence may be compen-
sated by Meis1 which may rescue some defects during
earlier phases of NCC development. Meis2 deficiency is
thus reflected in the areas and stages in which the Meis2
function is unique, e.g. during craniofacial development.
Meis proteins may diversify in their expression pattern
after the initial NCC specification and acquire unique
function, for instance, during formation of the OFT and
cartilage. In order to test this hypothesis it will be neces-
sary to generate and analyze Meis1 and Meis2 condi-
tional double mutants that may reveal potentially earlier
role of Meis factors during NCC development.
Even though we did not see a major difference in Sox9
expression in early embryos, anomalies in the craniofa-
cial skeleton of Wnt1-Cre/Sox9 cKO [47] and our
AP2α-Cre/Meis2 cKO are similar in the mandible,
tongue, the otic capsule and the hyoid bone. This sug-
gests that Sox9 and Meis2 cooperate in a similar differ-
entiation process during chondrogenesis. It remains to
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be elucidated what genes are direct targets of Meis fac-
tors. Altogether, our loss-of-function studies show that
Meis2 transcription is an important player in the gene
regulatory network determining differentiation of cardiac
and cranial NCC.
Methods
Generation of Meis2 null mice
The LoxP recognition elements for the Cre recombinase
were inserted in the introns 2 and 6 of the Meis2 gene at
the Gene Targeting & Transgenic Facility, University of
Connecticut, USA. Transgenic mice termed Meis2 cKO
were created by standard techniques using homologous
recombination in mouse embryonic stem cells (129SvEv-
Tac/C57BL/6 J F1) also at the Gene Targeting & Trans-
genic Facility. A neomycin selection cassette was removed
using FLP-FRT recombination. Meis2 cKO were crossed
to Hprt-Cre mice (strain 129S1/Sv-Hprttm1(cre)Mnn/J, stock
004302, The Jackson Laboratory) with the zygotic activity
of the Cre recombinase to obtain animals that were het-
erozygous for Meis2 (Meis2+/-) in the mixed genetic
background. Primers for genotyping Meis2+/- alleles:
Mrg1-lox-F (forward) GAGGGGACAGTGGGTAAACA,
Mrg1-frt-R (reverse) TCAGACCCAGGAATTTGAGG, a
PCR product of 256 bp. Wild-type allele: Mrg1-frt-F
GCAAGGGTGCTGAGGTTAAA and Mrg1-frt-R TCA
GACCCAGGAATTTGAGG, a PCR product 235 bp.
(Fig. 1a). Alternatively, Mrg1-lox-F GAGGGGACAGTG
GGTAAACA, Mrg1-lox-R GCGTTGCAGCTCACAAGA
AT, a PCR product of 142 bp.
All procedures involving experimental animals were
approved by the Institutional Committee for Animal
Care and Use (permission #PP-071/2011). This work did
not include human subjects.
Immunohistochemistry
Embryos were fixed in 4 % paraformaldehyde overnight
at 4 °C. 8-10 μm cryosections or 5-μm (paraffin-embed-
ded) sections were permeabilized in 0.1 % Triton X-100
in PBS (PBT). After blocking sections were incubated
overnight in a primary antibody (1 % BSA in PBT),
washed with PBS and incubated with a fluorescent sec-
ondary for 1 h. Nuclei were visualized by DAPI (4,6-dia-
midino-2-phenylindol, 0.1 μg ml− 1, Roche). Primary
antibodies: anti-Meis2 and anti-Meis1 (a gift from Dr.
Buchberg), anti-Myl7 (1:250, Santa Cruz), smooth
muscle actin (SMA) (1:1000, Sigma), Sox10, Twist1 (all
Santa Cruz Biotech), 2H3 (neurofilaments), 3B5 (Tfap2a)
and Pax3 (all DSHB), anti-alpha sarcomeric actin clone
5C5, anti-alpha smooth muscle actin clone 1A4 (both
Sigma), anti-Myl7 (H60) (Santa Cruz Biotech), Mitf (a
gift from Dr. H. Arnheiter), anti-Ter119 (BD Pharmin-
gen). Secondary antibodies: anti-mouse (-rat, -rabbit)
Alexa Fluor488 or 594 (Life Technologies). Biotinylated-
anti-mouse, -anti-rabbit, -anti-rat (Vector Laboratories),
Vectastain ABC Elite kit and ImmPACT DAB substrate
(all Vector Laboratories). Images were acquired in Leica
MZ APO stereomicroscope with DC200 camera or
Olympus SZX9 with DP72 camera. Fluorescence images
were acquired in Zeiss Axioskop 2 microscope with ob-
jectives Ph3 Plan-Neofluar 40x/1.3 oil or Ph1 Plan-
Neofluar 10x/0.3 and confocal Leica SP5. Bright-field
light images were acquired in Nikon Diaphot 300 with
objectives 4x/0.1 and 10x/0.25.
Scale2 protocol
Dissected embryonic hearts were fixed overnight in 4 %
PFA, washed in PBS and transferred into ScaleA2 re-
agent (4 M urea, 10 % glycerol, 0.1 % triton X-100) as
described in [49]. After two hours at RT hearts were
photographed.
Alcian blue/Alizarin red staining
Embryos at E16.5-17.5 were dissected and scalded in hot
water (65-70 °C, 2 min). They were dehydrated in 95 %
ethanol for 48-72 h, changing solution every 12 h. After
Alcian blue (Sigma) staining for 12 h, they were rinsed
twice in ethanol and kept overnight. After clearing in
1 % KOH for 2 h and they were stained with Alizarin
red (Sigma) for 5 h. Further clearing in 2 % KOH was
carried out overnight, then in Glycerol (25 %) and 2 %
KOH (75 %) for 8 h and Glycerol (50 %) and 2 % KOH
(50 %) for 48 h. Tissue sections were rehydrydated and
stained in 0.04 % Alcian solution for 10 min. Pictures
were obtained using binocular microscope Olympus
SYX9 and camera Olympus DP72.
Whole-mount in situ hybridization
Riboprobes: Mouse Foxd3 was cloned into pGEM-T-
easy vector (Promega) using primers F-GGACCGCAA
GAGTTCGCGGA, R-TCCGGAGCTCCCGTGTCGTT
and antisense mRNA was transcribed with T7 polymer-
ase. Mouse Sox9 gene was cloned into pGEM-T-easy
using primers F-GAGCACTCTGGGCAATCTCAG, R-
CTCAGGGTCTGGTGAGCTGTG and antisense mRNA
was transcribed with T7 polymerase. Whole-mount in situ
hybridization was performed using standard protocols.
Conclusions
We present a pioneering functional description of Meis2,
a member of TALE-class homeodomain transcription
factors, which is strongly expressed in cranial neural
crest cells. We generated a conditional allele of the
Meis2 gene. Using systemic and neural crest-specific in-
activation of Meis2, we provide evidence that Meis2 is
an important player in the regulatory network control-
ling cranial and cardiac neural crest cells.
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Additional file
Additional file 1: Figures S1-S4. Fetal liver in Meis2-/- at E13.5
contains less erythrocytes and loses cell viability. Figure S2. Meis2 is
abundant in the mesenchyme of the aorta-gonadmesonephros (AGM).
Figure S3. Meis2 is strongly expressed in migrating NCC and in mesen-
chymal cells at E10.5. Figure S4. Proliferation and cell death of migrating
NCC appears normal in Meis2-/- mutants. (PDF 1406 kb)
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